Two biologic injections, marketed side by side — but one is a mature, well-studied tool and the other is investigational, expensive, and the subject of repeated FDA warning letters. Here's how LAOSS specialists actually think about stem cells vs PRP for knee arthritis and joint pain.
We offer PRP. We don't offer stem cell injections for joint OA — and we'll tell you why.
Walk into a typical regenerative medicine clinic and you'll often see PRP and 'stem cell' injections listed next to each other on the same menu, with comparable language and dramatically different prices. That marketing framing isn't accurate to what these treatments actually are or where the evidence sits.
Platelet-rich plasma (PRP) is a concentrated dose of growth factors from your own blood. A small sample is drawn, spun in a centrifuge to concentrate platelets, and re-injected — usually under ultrasound guidance — into the injured tendon or joint. PRP has been studied in orthopedics for over two decades. The evidence is strong for some uses (tennis elbow, patellar tendinopathy) and moderate for others (mild-to-moderate knee OA, plantar fasciitis). Cost runs $500–$1,500 per injection. It's not covered by insurance, but it's a mature procedure with a known risk profile.
'Stem cell' injections for joint OA, as currently marketed in the United States, are almost always one of two things: bone marrow aspirate concentrate (BMAC) — cells harvested from the patient's pelvis — or adipose-derived stem cells, harvested from a small liposuction. Neither is FDA-approved for treating joint osteoarthritis. There are no large randomized controlled trials supporting their routine use. Real costs at clinics that aggressively market them run $3,000 to $8,000+ per joint, almost never covered.
The honest summary at LAOSS: we offer PRP. We don't offer stem cell injections for joint osteoarthritis — because the evidence does not yet support recommending them to patients at current price points. This page exists so you can make an informed call before you spend several thousand dollars on a procedure being sold past its evidence base.
Biologic injections like PRP use signals from your own body to stimulate tissue repair. This short video walks through what a guided in-office biologic injection looks like and how it fits into a non-surgical care plan.
Animations licensed from ViewMedica · Swarm Interactive
In an arthritic knee, cartilage is worn, the synovium is inflamed, and the tissue's intrinsic repair signaling is overwhelmed. PRP works by amplifying the signal: a concentrated dose of platelet-derived growth factors recruits healing cells already in the tissue. Bone marrow or adipose-derived 'stem cell' injections attempt a different mechanism — adding progenitor cells directly to the joint. In practice, the cell concentrations in BMAC and adipose preparations are highly variable, only a small fraction are true mesenchymal stem cells, and the survival and behavior of those cells inside a damaged joint is still an active research question. The mechanistic case is interesting; the clinical case for routine use at $5,000 per shot is not yet there.
There's no universal answer, but the decision for a patient considering 'stem cell vs PRP' usually breaks down along four axes: diagnosis, evidence quality, cost, and what the marketing is actually saying.
Diagnosis. For most orthopedic problems where biologics help — tennis elbow, patellar tendinopathy, mild-to-moderate knee OA, plantar fasciitis — PRP is the better-supported option. For end-stage joint disease, neither biologic injection meaningfully changes the trajectory. The honest conversation there is about joint replacement, not another injection.
Evidence quality. PRP has 20+ years of published data, with thousands of patients across randomized trials. The evidence is strong for some indications and mixed for others — we'll tell you which camp your diagnosis falls into. 'Stem cell' injections for joint OA have small case series, a handful of small RCTs, and inconsistent preparation methods between clinics. There is no large-scale evidence base supporting routine use.
Cost. PRP is $500–$1,500 per injection. A typical course is 1–3 injections. Stem cell injections at clinics that aggressively market them are $3,000–$8,000 per knee, sometimes more. Neither is covered by insurance. The cost gap is roughly 5x to 10x — for a treatment with substantially weaker evidence.
What the marketing is saying. If a clinic is selling 'stem cells' as a cure for arthritis, promising to 'regrow cartilage,' or pushing a same-day cash-pay decision, that's a real warning sign. The FDA has issued multiple warning letters to clinics making exactly those claims. Honest framing sounds like: 'This is investigational, this is what the published evidence does and doesn't show, and here's why it costs what it costs.' If you don't hear that, slow down.
For nearly every patient asking us about 'stem cells vs PRP' for joint pain, the right answer is to take PRP seriously and treat stem cell injections as investigational. Here's how we frame the two paths.
When biologics are appropriate at all, PRP is the better-evidenced, lower-cost option — and it's what we offer at LAOSS.
Stem cell injections for joint OA may eventually have a role — but at current price points and evidence levels, we don't recommend them as routine care. If you're considering one elsewhere, here's what we'd ask.
This part matters. The FDA has spent years pushing back on clinics marketing 'stem cell therapy' for arthritis, and the regulatory picture is materially different from PRP.
PRP is considered a minimally manipulated autologous product. It is a long-established part of orthopedic and sports medicine practice, with established procedural codes and a known safety profile.
The FDA has issued multiple warning letters to clinics marketing 'stem cell therapy' for orthopedic conditions, particularly when marketing claims cross into 'cure,' 'regenerate cartilage,' or treatment of conditions without an approved indication.
Cost is usually the place patients feel the gap most concretely — and we quote real numbers, not 'starting at' marketing prices.
PRP is self-pay at virtually every clinic. We quote the exact number at evaluation, and most courses run 1–3 injections.
Real-world pricing at clinics that market stem cell injections for joint OA, with the major caveat that pricing is wildly inconsistent and 'package' upsells are common.
We'll give you the honest read on the orthopedic literature for both — neither inflated nor dismissive.
PRP's evidence base is mature enough to give clear guidance on which indications support it and which don't.
The published literature on stem cell injections for joint OA is real but limited. It does not yet support routine clinical use at current prices.
These checklists are a starting point — the final call comes at your evaluation, with imaging and exam findings in front of us.
PRP is the better-supported biologic for the orthopedic conditions where biologics help at all — and it's what we offer at LAOSS.
We don't offer stem cell injections for joint OA, and these are the situations where we'd specifically steer you away from a clinic that does.
The decision rarely comes down to 'which biologic is better' in the abstract. Here's how three common patients land — and why the answer for most of them isn't a stem cell injection.
Wants to stay active and delay replacement. Steroid worked for a few weeks last year but wore off. PT helped a little.
Done eccentric loading, tried a brace, tried two cortisone shots. Pain still limits work. Considering surgery.
Severe pain, mechanical symptoms, MRI shows full-thickness cartilage loss. Has been quoted $7,500 for stem cells at a regenerative clinic.
It's a fair question — if every regenerative clinic on the Westside is offering stem cell shots, why aren't we?
The answer is simple: the evidence doesn't yet support recommending them at current price points. We've watched this space for years. The mechanistic story is interesting. A handful of small studies are encouraging. But there is no large randomized trial showing that bone marrow aspirate or adipose-derived stem cell injections produce reliably better outcomes than PRP for knee osteoarthritis — and the cost differential is roughly 5x to 10x. Charging a patient $5,000 to $8,000 for a procedure with a thinner evidence base than the $1,000 option isn't something we're willing to do.
This isn't a permanent position. If high-quality RCTs eventually show that a specific stem cell preparation, at a specific concentration, in a specific patient population, produces durable benefit that justifies the cost — we'll add it. The FDA may eventually approve a specific stem cell product for joint OA. We'll be early adopters of evidence-based regenerative care when the evidence gets there.
What we won't do is market past where the data is. If a clinic is selling you stem cells aggressively for knee arthritis, ask three questions: (1) What is the FDA approval status of this specific product? (2) What is the published evidence for this specific preparation in this specific joint? (3) What is the all-in cost, including follow-ups and repeats? Those three questions usually clarify the conversation quickly.
Both injections involve a needle into joint or tendon tissue — the procedural risk profiles are broadly similar. The bigger considerations are different.
PRP uses your own blood, so allergic reaction is essentially nonexistent. Procedural risks are small and well-characterized.
Procedural risks are similar to PRP, but harvest steps (bone marrow aspiration or liposuction) add their own. The biggest considerations are evidence and cost.
PRP and other biologic injections at LAOSS are performed by board-certified pain management physicians and sports medicine surgeons with deep training in ultrasound- and fluoroscopy-guided injection technique. The same physician who does your diagnostic ultrasound prepares the sample and performs the injection — no hand-offs to ancillary staff, no marketing-driven 'packages,' and an explicit promise to tell you when a biologic isn't the right tool for your problem.
Dr. Acosta saved me from spine surgery. I came in convinced I was going to need an operation. He laid out a non-surgical plan that's been working. So thankful.
Book a visit at any of our eight Los Angeles-area offices. We'll examine the joint, image it on-site, and tell you straight whether PRP, viscosupplementation, surgical consult, or something else is the right next step — and we'll save you from a $5,000+ shot that doesn't fit your situation.
